https://www.blincytohcp.com/
CD19-Positive B-Cell Precursor ALL Therapy | BLINCYTO® (blinatumomab)
Learn about BLINCYTO®, a treatment for CD19-positive MRD(+), R/R, and consolidation B-cell precursor ALL. See Full Safety Info, including Boxed Warning.
b cellall therapypositiveprecursorblinatumomab
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT02003222&r=1
Combination Chemotherapy with or without Blinatumomab in Treating Patients with Newly Diagnosed...
Combination Chemotherapy with or without Blinatumomab in Treating Patients with Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
combinationchemotherapywithout
https://adisinsight.springer.com/drugsafety/803508797?error=cookies_not_supported&code=73cf0c24-ca10-4b81-b759-d9cbf7d37c0f
Blinatumomab/inotuzumab-ozogamicin - AdisInsight
In a retrospective study of 31 patients who were treated with monoclonal antibodies in Spain between January 2016 and July 2019 (patients data retrieved from
inotuzumab ozogamicinblinatumomabadisinsight
https://adisinsight.springer.com/drugsafety/803924219?error=cookies_not_supported&code=bd7b23a7-59f7-4a03-8b6b-5d77a5e77332
Blinatumomab/Car-nk cell therapies - AdisInsight
A boy with relapsed B-cell acute lymphoblastic leukaemia (B-ALL) experienced lack of efficacy with blinatumomab and autologous CD19-targeted CAR-T cell therapy,
nk cellblinatumomabcartherapiesadisinsight
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-blinatumomab-for-children-and-young-people-with-a-certain-type-of-acute-lymphoblastic-leukaemia
A trial of blinatumomab for children and young people with a certain type of acute lymphoblastic...
This trial looked at a drug called blinatumomab for children and teenagers with a type of acute lymphoblastic leukaemia (ALL) called B cell precursor ALL.
for children and young people
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=38b482a8-960b-4591-9857-5031ecb830aa
DailyMed - BLINCYTO- blinatumomab kit
dailymedblincytoblinatumomabkit
https://seer.cancer.gov/oncologytoolbox/canmed/hcpcs/1205/
J9039 Blinatumomab - CanMED: HCPCS
CanMED: HCPCS. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
blinatumomabhcpcs
https://adisinsight.springer.com/drugsafety/803923058?error=cookies_not_supported&code=bbb6a64d-c661-4157-8c68-0a7d6a4bbfe9
Blinatumomab - AdisInsight
Five children with relapsed or refractory B-cell acute lymphoblastic leukaemia received blinatumomab and subsequently underwent allogeneic haematopoietic stem
blinatumomabadisinsight
https://adisinsight.springer.com/drugsafety/803578241?error=cookies_not_supported&code=7f235cba-3b3a-44db-b49b-dbe58fd3c851
Blinatumomab - AdisInsight
A 14-year-old girl developed progressive multiple leukoencephalopathy and neurotoxicity during treatment with blinatumomab for refractory acute lymphoblastic
blinatumomabadisinsight
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-blinatumomab-expanded-t-cells
Definition of autologous blinatumomab-expanded T cells - NCI Drug Dictionary - NCI
Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes...
definition ofautologousblinatumomabexpandedcells
https://www.nice.org.uk/guidance/ta450
Overview | Blinatumomab for previously treated Philadelphia-chromosome-negative acute lymphoblastic...
Evidence-based recommendations on blinatumomab (Blincyto) for treating Philadelphia-chromosome-negative precursor B-cell acute lymphoblastic leukaemia in adults
philadelphia chromosomeoverviewblinatumomabpreviouslytreated
https://adisinsight.springer.com/drugsafety/803803503?error=cookies_not_supported&code=3a3103f5-7a5b-445e-a7f8-049f16561c84
Blinatumomab/pneumococcal-vaccine - AdisInsight
A 27-month-old boy developed Streptococcus pneumoniae infection and hypogammaglobulinaemia during treatment with blinatumomab. He also exhibited vaccine failure
pneumococcal vaccineblinatumomabadisinsight
https://pubmed.ncbi.nlm.nih.gov/33651091/
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk...
ClinicalTrials.gov Identifier: NCT02393859.